Table 1.
Professionals | Patient research partners | |||
---|---|---|---|---|
Sex (M:F) | 12:4 | 7:9 | Interview code | |
Professional background or diagnosis | 10 practising rheumatologists | 10 rheumatoid arthritis | ||
3 full-time researchers | 2 vasculitis | |||
3 other professionals | 2 ankylosing spondylitis | |||
1 fibromyalgia | ||||
1 gout | ||||
Number of OMERACT conferences attended | ||||
1 | 5 | 8 | PA to PF, PO, PP | |
2 | 0 | 3 | } | PG to PN |
3 | 1 | 1 | ||
4 | 4 | 4 | ||
≥5 | 6 | 0 | ||
Interview in relation to OMERACT conference | ||||
Before | 2 | 1 | ||
During | 8 | 16 | ||
After | 6 | 5 | ||
Geographical spread | ||||
6 countries | 7 countries | |||
2 continents | 4 continents | |||
Research background | ||||
10 senior researchers | RA to RG, RJ, RK, RY | |||
1 research fellow | RH | |||
1 postdoctoral researcher | RI | |||
2 pharma representatives | DA, DD | |||
2 staff members | DB, DC |
OMERACT, Outcome Measures in Rheumatology.